EliGene® COVID19 UKV RT Kit, 100 reactii , cod catalog 90082-RT

EliGene® COVID19 UKV RT Kit, 100 reactii , cod catalog 90082-RT

EliGene® COVID19 UKV/SAV RT Kit, 100 reactii , cod catalog 90083-RT

EliGene® COVID19 UKV/SAV RT Kit, 100 reactii , cod catalog 90083-RT

EliGene® COVID19 UKV RT Kit, 500 reactii , cod catalog 90082-RT-500

29.744,05 RON
SKU
ELI_90082-RT-500

EliGene® COVID19 UKV RT Kit (REF: 90082-RT-500) is intended for qualitative RNA detection of SARS-CoV-2 virus, in parallel with the genotyping of the of the mutations N501Y and P681H present in spike protein characteristic for the variant B.1.1.7 (20I/501Y.V1) also called UK variant.

Benfits and features:

 

  • CE mark
  • Quick and affordable one-pot option to distinguish between wild-type and UK variant of SARS-CoV-2 virus in comparison to sequencing genotypization
  • The co-occurence of both mutations N501Y and P681H is specific for genetic lineage B.1.1.7.
  • Primers and probes adopted from the literature and/or approved by the authorities like WHO, CDC, or ECDC
  • Suitable for RNA isolated from all types of clinical samples
  • Special technology developed in EU by Elisabeth Pharmacon company
  • Increased specifity due to multiple independent targets
  • Compatible with all Elisabeth Pharmacon viral isolation kits
  • Increased sensitivity enables to detect from the number of 5 genomic RNA copies

Mai multe informatii
Price 24.995,00 RON (preturile sunt fara TVA)
Description

EliGene® COVID19 UKV RT Kit (REF: 90082-RT-500) is intended for qualitative RNA detection of SARS-CoV-2 virus, in parallel with the genotyping of the of the mutations N501Y and P681H present in spike protein characteristic for the variant B.1.1.7 (20I/501Y.V1) also called UK variant.

Benfits and features:

 

  • CE mark
  • Quick and affordable one-pot option to distinguish between wild-type and UK variant of SARS-CoV-2 virus in comparison to sequencing genotypization
  • The co-occurence of both mutations N501Y and P681H is specific for genetic lineage B.1.1.7.
  • Primers and probes adopted from the literature and/or approved by the authorities like WHO, CDC, or ECDC
  • Suitable for RNA isolated from all types of clinical samples
  • Special technology developed in EU by Elisabeth Pharmacon company
  • Increased specifity due to multiple independent targets
  • Compatible with all Elisabeth Pharmacon viral isolation kits
  • Increased sensitivity enables to detect from the number of 5 genomic RNA copies